GWW vs RGEN · P/E 27, rev $9.76B vs P/E 143, rev $204.1M
WW Grainger Inc (GWW) versus Repligen Corporation (RGEN) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Repligen Corporation (RGEN) is a medical instruments & supplies company listed on NASDAQ.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported RGEN revenue for 2026-06-30 was $204.1M. Net income was $5.0M. Revenue was up 5.1% from 2026-03-31 to 2026-06-30. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.
Not investment advice. Open the GWW and RGEN stock pages for the full models.
Not investment advice.